Skip to main content
Fig. 2 | Journal of Nanobiotechnology

Fig. 2

From: Development of multivalent nanobodies blocking SARS-CoV-2 infection by targeting RBD of spike protein

Fig. 2

Expression, purification and binding ability determination of monovalent nanobodies. a Schematic presentation of the vector for nanobody expression in mammalian cells. b SDS-PAGE detection of the expression and purification of recombinant nanobody-hFc fusions (55 kDa). M: Marker; lane 1: Nb82-hFc; lane 2: Nb91-hFc; lane 3: Nb3-hFc; lane 4: Nb35-hFc. c Measurement the binding ability of recombinant monovalent nanobodies using indirect ELISA

Back to article page

Journal of Nanobiotechnology

ISSN: 1477-3155

Contact us